Matrixyl 3000
Matrixyl 3000. Topical peptide blend that signals fibroblasts to produce collagen and ECM proteins.
How it works. Mimics endogenous matrikine signals from collagen breakdown, prompting fibroblasts to synthesize collagen, elastin, and hyaluronic acid.
What the research supports. 2 graded claims. Strongest: Gentle, well-tolerated mechanism (preclinical).
Hormonal impact. Effects on Local fibroblast signaling.
Side effects and interactions. 0 medication interactions listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Sunscreen, retinoid, and vitamin C. Avoid combining with Active inflammatory skin disease.
Common forms. Available as Topical serums and creams.
Community. Experiences from people who have tried Matrixyl 3000. Anecdotes are not medical advice.
Matrixyl 3000. Topical peptide blend that signals fibroblasts to produce collagen and ECM proteins.
What it is
Matrixyl 3000 combines two palmitoylated signal peptides that target dermal fibroblasts to upregulate extracellular matrix protein synthesis.
Also called
How it works
Mimics endogenous matrikine signals from collagen breakdown, prompting fibroblasts to synthesize collagen, elastin, and hyaluronic acid.
Pathways
- Matrikine signaling
- Fibroblast activation
- Collagen I and III synthesis
Effects
- +Dermal collagen and elastin synthesis supports
- ↓Fine line depth over time decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Hormonal impact
Side effects & interactions
Common side effects
- Mild irritation
No notable medication interactions listed.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Sunscreen, retinoid, and vitamin CCombined prevention plus signaling support.
Avoid combining
- Active inflammatory skin diseaseDefer until barrier is restored.
Common forms
- Topical serums and creams
Discussion
Loading discussion…